Exact Mass: 406.1416
Exact Mass Matches: 406.1416
Found 272 metabolites which its exact mass value is equals to given mass value 406.1416
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Morroniside
Morroniside is a glycoside. Morroniside is a natural product found in Lonicera japonica, Tripterospermum japonicum, and other organisms with data available. Morroniside has neuroprotective effect by inhibiting neuron apoptosis and MMP2/9 expression. Morroniside has neuroprotective effect by inhibiting neuron apoptosis and MMP2/9 expression.
Asperlicin C
A member of the class of asperlicins in which the core 6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione skeleton is substituted at the 7 pro-S position by an indol-3-ylmethyl group. It is a cholecystokinin antagonist.
Bicyclomycin benzoate
Morroniside
Palomid 529
Palomid 529 is a potent inhibitor of mTORC1 and mTORC2 complexes. Palomid 529 is a potent inhibitor of mTORC1 and mTORC2 complexes.
Pamapimod
Shanzhiside methyl ester
Acetylharpagide
8-O-Acetylharpagide is a natural product found in Scrophularia deserti, Scrophularia scorodonia, and other organisms with data available. 8-O-Acetylharpagide is an iridoid isolated from Ajuga reptans with antitumoral, antiviral, antibacterial, and anti-inflammatory activities. 8-O-Acetylharpagide also has a biological activity on isolated smooth muscle preparations from guinea pig[1][2]. 8-O-Acetylharpagide is an iridoid isolated from Ajuga reptans with antitumoral, antiviral, antibacterial, and anti-inflammatory activities. 8-O-Acetylharpagide also has a biological activity on isolated smooth muscle preparations from guinea pig[1][2].
ACon0_000910
Shanzhiside methyl ester is a glycoside and an iridoid monoterpenoid. Shanzhiside methyl ester is a natural product found in Barleria lupulina, Pedicularis decora, and other organisms with data available. Shanzhiside methy lester is isolated from lamiophlomis rotata. Shanzhiside methyl ester is a small molecule glucagon-like peptide-1 (GLP-1) receptor agonist and has the ability to induce anti-allodynic tolerance[1]. Shanzhiside methy lester is isolated from lamiophlomis rotata. Shanzhiside methyl ester is a small molecule glucagon-like peptide-1 (GLP-1) receptor agonist and has the ability to induce anti-allodynic tolerance[1].
Shanzhiside
Shanzhiside methyl ester is a glycoside and an iridoid monoterpenoid. Shanzhiside methyl ester is a natural product found in Barleria lupulina, Pedicularis decora, and other organisms with data available. Shanzhiside methy lester is isolated from lamiophlomis rotata. Shanzhiside methyl ester is a small molecule glucagon-like peptide-1 (GLP-1) receptor agonist and has the ability to induce anti-allodynic tolerance[1]. Shanzhiside methy lester is isolated from lamiophlomis rotata. Shanzhiside methyl ester is a small molecule glucagon-like peptide-1 (GLP-1) receptor agonist and has the ability to induce anti-allodynic tolerance[1].
Shanzhiside methyl ester
Shanzhiside methy lester is isolated from lamiophlomis rotata. Shanzhiside methyl ester is a small molecule glucagon-like peptide-1 (GLP-1) receptor agonist and has the ability to induce anti-allodynic tolerance[1]. Shanzhiside methy lester is isolated from lamiophlomis rotata. Shanzhiside methyl ester is a small molecule glucagon-like peptide-1 (GLP-1) receptor agonist and has the ability to induce anti-allodynic tolerance[1].
8-Acetylharpagide
Origin: Plant; SubCategory_DNP: Monoterpenoids, Harpagide monoterpenoids 8-O-Acetylharpagide is an iridoid isolated from Ajuga reptans with antitumoral, antiviral, antibacterial, and anti-inflammatory activities. 8-O-Acetylharpagide also has a biological activity on isolated smooth muscle preparations from guinea pig[1][2]. 8-O-Acetylharpagide is an iridoid isolated from Ajuga reptans with antitumoral, antiviral, antibacterial, and anti-inflammatory activities. 8-O-Acetylharpagide also has a biological activity on isolated smooth muscle preparations from guinea pig[1][2].
6beta-Hydroxyadoxoside
(-)-(7S,8S)-threo-1-C-syringylglycerol 4-O-beta-D-glucopyranoside
(-)-(7R,8R)-syringylglycerol 9-O-beta-D-glucopyranoside|(1R,2R)-1-syringylglycerol 3-O-beta-D-glucopyranoside
OCHROCARPIN C
A furanocoumarin that is 2H-furo[2,3-h]chromen-2-one substituted by a hydroxy group at position 5, 2-hydroxypropan-2-yl group at position 8, a 2-methylpropanoyl group at position 6 and a phenyl group at position 4. Isolated from the bark of Ochrocarpos punctatus, it exhibits cytotoxicity against the A2780 ovarian cancer cell line.
methyl (1S,4aS,7R,7aS)-7-hydroxy-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylate
(6aS)-3-(2-hydroxy-6-methylphenyl)-6a-methyl-9-(2-methylbutyryl)-6aH-furo[2,3-h]isochromene-6,8-dione|multiformin C
(2R,3S)-trans-2-(4-hydroxy-3-methoxyphenyl)-2,3,5,6-tetrahydrophenanthro[2,1-b]pyran-3,8,11-triol|chrysotoxol A
(1S,3R,5R,7S,8S,9S)-5,8-dihydroxy-3-methoxy-1-isovaleroxyvalechlorine|chlorovaltrate B
(-)-(7R,8R)-syringylglycerol 8-O-beta-D-glucopyranoside
(1S,5R,7S,8S,9S)-7-acetoxy-10-chloro-5-hydroxy-1-isovaleroxy-11-methoxy-5,6-dihydrovaltrate chlorohydrin|chlorovaltrate H
2-(1,3-Benzodioxole-5-ylcarbonyl)-1-(4-methoxybenzofuran-5-yl)-3,3-dimethyl-4-pentene-1-one
C17H26O11_(1S,4aS,5R,7S,7aS)-1-(beta-D-Glucopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl acetate
C17H26O11_Methyl (1S,4aS,6R,7R,7aR)-1-(beta-D-glucopyranosyloxy)-5,6-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
C17H26O11_1-(Hexopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl acetate
C17H26O11_Methyl (1S,4aS,5R,7S,7aS)-1-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
methyl (1S,4aS,6R,7R,7aR)-5,6-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
SB281832
CONFIDENCE standard compound; INTERNAL_ID 341; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7957; ORIGINAL_PRECURSOR_SCAN_NO 7956 CONFIDENCE standard compound; INTERNAL_ID 341; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7921; ORIGINAL_PRECURSOR_SCAN_NO 7919 CONFIDENCE standard compound; INTERNAL_ID 341; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7996; ORIGINAL_PRECURSOR_SCAN_NO 7995 CONFIDENCE standard compound; INTERNAL_ID 341; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8005; ORIGINAL_PRECURSOR_SCAN_NO 8002 CONFIDENCE standard compound; INTERNAL_ID 341; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7977; ORIGINAL_PRECURSOR_SCAN_NO 7976 CONFIDENCE standard compound; INTERNAL_ID 341; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8009; ORIGINAL_PRECURSOR_SCAN_NO 8006
Ala Asp Asp Ser
Ala Asp Ser Asp
Ala Ser Asp Asp
Cys Gly Met Pro
Cys Gly Pro Met
Cys Met Gly Pro
Cys Met Pro Gly
Cys Pro Gly Met
Cys Pro Met Gly
Asp Ala Asp Ser
Asp Ala Ser Asp
Asp Asp Ala Ser
Asp Asp Gly Thr
Asp Asp Ser Ala
Asp Asp Thr Gly
Asp Glu Gly Ser
Asp Glu Ser Gly
Asp Gly Asp Thr
Asp Gly Glu Ser
Asp Gly Ser Glu
Asp Gly Thr Asp
Asp Ser Ala Asp
Asp Ser Asp Ala
Asp Ser Glu Gly
Asp Ser Gly Glu
Asp Thr Asp Gly
Asp Thr Gly Asp
Glu Asp Gly Ser
Glu Asp Ser Gly
Glu Gly Asp Ser
Glu Gly Ser Asp
Glu Ser Asp Gly
Glu Ser Gly Asp
Gly Cys Met Pro
Gly Cys Pro Met
Gly Asp Asp Thr
Gly Asp Glu Ser
Gly Asp Ser Glu
Gly Asp Thr Asp
Gly Glu Asp Ser
Gly Glu Ser Asp
Gly Met Cys Pro
Gly Met Pro Cys
Gly Pro Cys Met
Gly Pro Met Cys
Gly Ser Asp Glu
Gly Ser Glu Asp
Gly Thr Asp Asp
5-((2-hydroxy-2-methylpropoxy)carbonyl)-2-(hydroxymethyl)-6-methyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid
Met Cys Gly Pro
Met Cys Pro Gly
Met Gly Cys Pro
Met Gly Pro Cys
Met Pro Cys Gly
Met Pro Gly Cys
Pro Cys Gly Met
Pro Cys Met Gly
Pro Gly Cys Met
Pro Gly Met Cys
Pro Met Cys Gly
Pro Met Gly Cys
Ser Ala Asp Asp
Ser Asp Ala Asp
Ser Asp Asp Ala
Ser Asp Glu Gly
Ser Asp Gly Glu
Ser Glu Asp Gly
Ser Glu Gly Asp
Ser Gly Asp Glu
Ser Gly Glu Asp
Thr Asp Asp Gly
Thr Asp Gly Asp
Thr Gly Asp Asp
Methyl (1S,4aS,6R,7R,7aR)-1-(?-D-glucopyranosyloxy)-5,6-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
(3aR,4R,5R,6aS)-2-oxo-4-((E)-3-oxo-4-phenoxybut-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-5-yl benzoate
2-Propenoic acid, (4-methyl-1,3-phenylene)bis(iminocarbonyloxy-2,1-ethanediyl) ester
6-Epi-8-O-acetylharpagide
spiro(cyclohexane-1,3(1H)-furo(3,4-C)pyridine)-4-carboxamide, N-(1-(2-fluorophenyl)-1h-pyrazol-3-yl)-1-oxo-, trans-
MK-0557 is a highly selective, orally available neuropeptide Y5 receptor antagonist with a Ki of 1.6 nM.
Pamapimod
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-[4-(4-Fluorophenyl)-5-(2-phenoxypyrimidin-4-yl)imidazol-1-yl]propane-1,3-diol
N-(4-methyl-2-pyridinyl)-2-[3-(trifluoromethyl)phenyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carbothioamide
N-[[3-(2-chlorophenyl)-1-(4-fluorophenyl)-4-pyrazolyl]methyl]-2-(2-pyridinyl)ethanamine
Trp-Asp-Ser
A tripeptide composed of L-tryptophan, L-aspartic acid, and L-serine joined by peptide linkages.
(2S,3R,4R)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-(2-methylphenyl)sulfonyl-2-azetidinecarbonitrile
(2R,3S,4S)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-(2-methylphenyl)sulfonyl-2-azetidinecarbonitrile
(1S,5R)-3-(3-methylphenyl)sulfonyl-7-[4-(5-pyrimidinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
5-Hydroxy-8-(hydroxymethyl)-8-methyl-6-(2-methylpropanoyl)-4-phenylpyrano[2,3-h]chromen-2-one
(7S)-1-(beta-D-glucopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl acetate
(2,3,4,6-Tetraacetyloxy-6-deuterio-5-methoxyhexyl) acetate
methyl 4-(2,2-dihydroxyethyl)-5-ethenyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate
methyl (1s,6s,7r,7as)-6,7-dihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
4a,5-dihydroxy-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl acetate
methyl (4as,8as)-6-hydroxy-8-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,8h,8ah-pyrano[3,4-c]pyran-4-carboxylate
(4as,7s,7ar)-4a,5-dihydroxy-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl acetate
(2s)-5-hydroxy-8-[(2-hydroxy-5-methoxyphenyl)methyl]-7-methoxy-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(12r,15s,16s)-14,14,15-trimethyl-6-oxo-4-phenyl-3,11,13-trioxatetracyclo[8.6.0.0²,⁷.0¹²,¹⁶]hexadeca-1,4,7,9-tetraen-15-yl acetate
(6as)-3-(2-hydroxy-6-methylphenyl)-6a-methyl-9-[(2r)-2-methylbutanoyl]furo[2,3-h]isochromene-6,8-dione
2-[2,3-dihydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)propoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (1s,4as,5s,6s,7r,7ar)-5,6-dihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
(2s,3r,4s,5s,6r)-2-{2,6-dimethoxy-4-[(1s,2s)-1,2,3-trihydroxypropyl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s)-5-hydroxy-6-[(2-hydroxy-5-methoxyphenyl)methyl]-7-methoxy-2-phenyl-2,3-dihydro-1-benzopyran-4-one
methyl (1s,4ar,5r,7s,7ar)-4a,5-dihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
methyl (1s,4ar,6s,7s)-4a,6-dihydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
methyl 5-hydroxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate
(2r,3r,4s,5s,6r)-2-{[(1r,2s)-1,3-dihydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)propan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
6-epi-8-o-acetylharpagide
{"Ingredient_id": "HBIN012330","Ingredient_name": "6-epi-8-o-acetylharpagide","Alias": "NA","Ingredient_formula": "C17H26O11","Ingredient_Smile": "CC(=O)OC1(CC(C2(C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O)C","Ingredient_weight": "406.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6817","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21604822","DrugBank_id": "NA"}
(7s,8s)-syringoylglycerol9-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN013482","Ingredient_name": "(7s,8s)-syringoylglycerol9-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C17H26O11","Ingredient_Smile": "COC1=CC(=CC(=C1O)OC)C(C(CO)OC2C(C(C(C(O2)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "20555","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}